Company Filing History:
Years Active: 2016
Title: Zhenqian Wu: Innovator in Intestinal Mucosa Treatment
Introduction
Zhenqian Wu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical science, particularly in the treatment of intestinal mucosa injuries. His innovative approach has led to the development of a unique patent that addresses a critical health issue.
Latest Patents
Zhenqian Wu holds a patent for "Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 receptor antagonist." This invention provides a method for utilizing the interleukin-1 receptor antagonist protein to prepare a medicament aimed at preventing or treating epithelium trauma of the intestinal mucosa. The patent specifies that the protein can be selected from a protein with a specific amino acid sequence or a protein with at least 70% homology to that sequence, which effectively prevents or treats such trauma. The invention also includes a pharmaceutical composition comprising the active protein component.
Career Highlights
Zhenqian Wu is associated with General Regeneratives, Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on gastrointestinal health and treatment methodologies.
Collaborations
Zhenqian Wu collaborates with notable colleagues, including Wei Han and Di Xiang. Their combined expertise contributes to the ongoing development of innovative solutions in the medical field.
Conclusion
Zhenqian Wu's contributions to the treatment of intestinal mucosa trauma highlight his role as a key innovator in medical science. His patent reflects a significant advancement in therapeutic options for patients suffering from epithelial injuries.